Inhibition of Biofilm Organisms

Abstract

The present invention relates to a product comprising at least two antibiofilm agents wherein at least one of the antibiofilm agents is an antimicrobial peptide. The second antibiofilm agent is cysteamine. There is also provided the use of the product in the treatment of a microbial infection.

1 .- 51 . (canceled) 
     
     
         52 . A method of treating a biofilm in a patient, by prophylaxis or therapy, comprising administering to the patient a mucolytic agent wherein the mucolytic agent is cysteamine. 
     
     
         53 . The method of  claim 52  wherein the patient has cystic fibrosis. 
     
     
         54 . The method of  claim 52  wherein the biofilm is associated with an infection in cystic fibrosis. 
     
     
         55 . A method of treating a condition associated with cystic fibrosis, by prophylaxis or therapy, in a patient comprising administering to said patient a mucolytic agent wherein the mucolytic agent is cysteamine. 
     
     
         56 . The method of  claim 55  wherein the mucolytic agent is administered alone. 
     
     
         57 . A method of treating a bacterial infection in a cystic fibrosis patient comprising administering to said patient an amount of cysteamine effective to treat said infection.